By Dr Rachel Harding & Dr Sarah Hernandez
June 17, 2026
The Other Shoe Drops: uniQure Shares Plans To Submit Licensing Application With The FDA for AMT-130

“After a turbulent past year, uniQure have shared encouraging news that the FDA has agreed their Phase I/II study data can serve as the basis for an application that could lead to the approval of AMT-130 in the US.”
Read the full article: https://en.hdbuzz.net/the-
By Dr Rachel Harding & Dr Sarah Hernandez
uniQure Announces Successful UK MHRA Pre-Submission Meeting for AMT-130 in Huntington’s Disease
Bi-Monthly Advocacy Newsletter: Visit HDSA.org/Takeaction to read the New Bi-Monthly Advocacy Newsletter for updates.



